Carrie Smith Cox - Jun 10, 2022 Form 4 Insider Report for Organon & Co. (OGN)

Role
Director
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Carrie Smith Cox
Stock symbol
OGN
Transactions as of
Jun 10, 2022
Transactions value $
$199,994
Form type
4
Date filed
6/14/2022, 07:31 PM
Previous filing
Jan 31, 2022
Next filing
Jun 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Phantom Stock Award $200K +5.64K +30.41% $35.46 24.2K Jun 10, 2022 Common Stock 5.64K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
F2 Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
F3 Holdings include phantom stock acquired in dividend reinvestment transactions on September 13, 2021, December 16, 2021 and March 17, 2022.